First Advantage (FA) Earnings Analysis
First Advantage (FA) next reports earnings on 2026-08-06, consensus EPS 0.29 USD. Last quarter (2026-05-07) it beat with EPS 0.26 USD vs 0.21 USD est (+23.8%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 405.69.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does FA next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.29 USD |
| Revenue estimate | 0.42B |
FA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.26 USD | 0.21 USD | +23.8% | Beat |
| 2026-02-26 | 0.3 USD | 0.26 USD | +15.4% | Beat |
| 2025-11-06 | 0.3 USD | 0.28 USD | +7.1% | Beat |
| 2025-08-07 | 0.27 USD | 0.24 USD | +12.5% | Beat |
| 2025-05-08 | 0.17 USD | 0.13 USD | +30.8% | Beat |
| 2025-02-27 | 0.18 USD | 0.24 USD | -25% | Miss |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
FA valuation and analyst view
| Trailing P/E | 405.69 |
|---|---|
| Trailing EPS | 0.0491 USD |
| Price / book | 2.68 |
| Dividend yield | 0.00% |
| Market cap | 3.47B |
| Analyst consensus | Buy (7 buy / 5 hold / 0 sell) |
| Avg price target | 18 USD |
Related research pages
Frequently asked questions
When is First Advantage (FA)'s next earnings date?
First Advantage is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.29 USD and revenue estimate of 0.42B.
Did FA beat earnings last quarter?
In its 2026-05-07 report, FA posted EPS of 0.26 USD versus a 0.21 USD estimate — a beat of 23.8%.
What is FA's earnings track record?
Over the last 6 reported quarters with consensus data, FA beat estimates 5 times (83%).
What is FA's current P/E ratio and EPS?
FA trades at a trailing P/E of 405.69 on trailing EPS of 0.04909615886385347 USD.
What do analysts rate FA?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 7 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 18 USD.